Inventor · disambiguated record
Elliot Ehrich
Also filed as: EHRICH ELLIOT
14 granted patents·15 pending applications·233 citations·filing 2003–2021
93Inventor score
Files withALKERMES PHARMA IRELAND LTD13ALKERMES INC6CIVITAS THERAPEUTICS INC4EHRICH ELLIOT2ADVANCED INHALATION RES INC1
Top patents by PatentIndex Score
29 records- 0198US8822488B2Compositions of buprenorphine and μ antagonistsALKERMES PHARMA IRELAND LTD·Filed 2012·Granted Sep 2, 2014·57 cites·21 claims
- 0297US9211293B2Opioid agonist antagonist combinationsALKERMES PHARMA IRELAND LTD·Filed 2012·Granted Dec 15, 2015·49 cites·19 claims
- 0393US8747813B2Inhalable epinephrineCIVITAS THERAPEUTICS INC·Filed 2013·Granted Jun 10, 2014·27 cites·11 claims
- 0492US8415397B2Inhalable epinephrineBATYCKY RICHARD P·Filed 2011·Granted Apr 9, 2013·26 cites·24 claims
- 0592US7947742B2Inhalable epinephrineCIVITAS THERAPEUTICS INC·Filed 2003·Granted May 24, 2011·54 cites·8 claims
- 0688US9498474B2Compositions of buprenorphine and μ AntagonistsALKERMES PHARMA IRELAND LTD·Filed 2014·Granted Nov 22, 2016·6 cites·13 claims
- 0786US9918978B2Compositions of buprenorphine and μ antagonistsALKERMES PHARMA IRELAND LTD·Filed 2016·Granted Mar 20, 2018·3 cites·9 claims
- 0886US9913837B2Compositions of buprenorphine and μ antagonistsALKERMES PHARMA IRELAND LTD·Filed 2016·Granted Mar 13, 2018·3 cites·25 claims
- 0986US7919499B2Naltrexone long acting formulations and methods of useALKERMES INC·Filed 2005·Granted Apr 5, 2011·6 cites·15 claims
- 1084US10314838B2Compositions of buprenorphine and μ antagonistsALKERMES PHARMA IRELAND LTD·Filed 2017·Granted Jun 11, 2019·2 cites·18 claims
- 1178US10806731B2Compositions of buprenorphine and μ antagonistsALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Oct 20, 2020·0 cites·20 claims
- 1275US2021196703A1COMPOSITIONS OF BUPRENORPHINE AND µ ANTAGONISTSALKERMES PHARMA IRELAND LTD·Filed 2020·Application pending·0 cites
- 1374US2021244818A1Naltrexone Long Acting Formulations and Methods of UseALKERMES PHARMA IRELAND LTD·Filed 2021·Application pending·0 cites
- 1470US10758527B2Opioid agonist antagonist combinationsALKERMES PHARMA IRELAND LTD·Filed 2018·Granted Sep 1, 2020·0 cites·41 claims
- 1568US10188643B2Compositions of buprenorphine and μ antagonistsALKERMES PHARMA IRELAND LTD·Filed 2017·Granted Jan 29, 2019·0 cites·10 claims
- 1667US2009022823A1Methods for Administering Active Agents to CYP3A4 Sensitive PatientsALKERMES INC·Filed 2008·Application pending·0 cites
- 1761US10195191B2Opioid agonist antagonist combinationsALKERMES PHARMA IRELAND LTD·Filed 2015·Granted Feb 5, 2019·0 cites·25 claims
- 1860US2014155424A1Naltrexone long acting formulations and methods of useALKERMES INC·Filed 2013·Application pending·0 cites
- 1960US2015094378A1Inhalable EpinephrineCIVITAS THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2059US2018064814A1Naltrexone Long Acting Formulations and Methods of UseALKERMES PHARMA IRELAND LTD·Filed 2017·Application pending·0 cites
- 2158US2007041912A1Trospium containing compositionsADVANCED INHALATION RES INC·Filed 2003·Application pending·0 cites
- 2257US2009214650A1Methods of Treating alcoholism and alcohol related disorders using combination drug therapy and swellable polymersALKERMES INC·Filed 2007·Application pending·0 cites
- 2356US2017119699A1Inhalable epinephrineCIVITAS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2455US2005031713A1Methods for administering active agents to CYP3A4 sensitive patientsFiled 2003·Application pending·0 cites
- 2555US2011212985A1Naltrexone Long Acting Formulations and Methods of UseALKERMES INC·Filed 2011·Application pending·0 cites
- 2653US2007099947A1Methods and compositions for the treatment of brain reward system disorders by combination therapyALKERMES INC·Filed 2006·Application pending·0 cites
- 2752US2005032781A1Methods for administering active agents to CYP 2D6 sensitive patientsFiled 2003·Application pending·0 cites
- 2838US2005245461A1Methods for treating alcoholismEHRICH ELLIOT·Filed 2005·Application pending·0 cites
- 2938US2005245541A1Methods for treating alcoholismEHRICH ELLIOT·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elliot Ehrich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →